Rossmax International

Rossmax International Net Margin

The Net Profit Margin of Rossmax International (4121.TWO) as of Nov 1, 2026 is -0.79 %. In the previous year, Net Profit Margin was -0.76 % — a change of 3.26% (lower).

Net Margin

-0.79 %

YoY

3.26%

Last updated:

Net Profit Margin of Rossmax International is 2025 -0.79 % . Net Profit Margin of Rossmax International was 2024 -0.76 % . It decreases by 3.26% lower compared to the previous year.

Rossmax International's net margin stands at -0.8%, down from 2.8% several years earlier.

The Rossmax International Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
0.54 TWD
Jan 1, 2019
0.83 TWD
Jan 1, 2020
3.68 TWD
Jan 1, 2021
2.82 TWD
Jan 1, 2022
3.92 TWD
Jan 1, 2023
-0.17 TWD
Jan 1, 2024
-0.76 TWD
Jan 1, 2025
-0.79 TWD
The Rossmax International Net Margin history
YEARNet MarginYoY
-0.79 %+3.26%
-0.76 %+335.52%
-0.17 %-104.46%
3.92 %+38.91%
2.82 %-23.38%
3.68 %+342.81%
0.83 %+55.27%
0.54 %-38.96%
0.88 %+36.58%
0.64 %-178.90%
-0.81 %+895.34%
-0.08 %-1,950.36%
0.00-60.13%
0.01 %-21.00%
0.01 %-70.04%
0.05 %+78.71%
0.03 %-171.29%
-0.04 %-146.80%
0.08 %+163.31%
0.03 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rossmax International Stock analysis

What does Rossmax International do? Rossmax International Ltd, listed on the Taiwan Stock Exchange under ticker 4121.TWO with ISIN TW0004121009, is a healthcare company headquartered in Taipei City, Taiwan. Founded through an IPO on November 28, 2002, the company employs 965 people. It operates within the healthcare sector, focusing on the design, manufacture, research, and development of healthcare products. Its primary product lines include digital sphygmomanometers, respiratory therapy products, temperature series products, and blood oxygen meters. Rossmax distributes its products both domestically within Taiwan and internationally across markets in Europe, the Americas, and other regions. The company maintains a website at https://www.rossmax.com/ for further information. Rossmax International Ltd does not disclose specific financial figures or additional details beyond its operational scope and product offerings as provided in the source material. The company's activities are centered around healthcare innovation and product development aimed at meeting consumer health needs through technological solutions. Rossmax International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rossmax International stock

Net Profit Margin of Rossmax International is -0.79 % in 2025.

Net Profit Margin of Rossmax International changed from -0.76 % to -0.79 %, representing a 3.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Rossmax International since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Rossmax International with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Rossmax International

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Rossmax International